20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T80552 | Prostate Specific Antigen Substrate | ||
Prostate Specific Antigen Substrate is a fluorescent substrate specific to prostate specific antigen (PSA) and facilitates the detection of PSA enzymatic activity [1]. | |||
T23189 | prostate apoptosis response protein PAR-4 (2-7) [Homo sapiens] | Others | |
Prostate apoptosis response protein PAR-4 (2-7) [Homo sapiens] is a peptide with the sequence H2N-Ala-Thr-Gly-Gly-Tyr-Arg-OH, MW= 623.66. | |||
TN7020 | Astragenol | Others | |
Astragenol is an intermediate for the synthesis of astragenel derivatives. Astragenol derivatives are promising anti-inflammatory drugs in prostate cancer research. | |||
T22263 | Bavdegalutamide | ARV-110 | Androgen Receptor |
Bavdegalutamide (ARV-110) is a PROTAC degrader of androgen receptor (AR). Bavdegalutamide can be used in studies about prostate cancer. Bavdegalutamide shows oral activity and selectivity and facilitates the ubiquitinati... | |||
T8188 | Podophyllotoxone | Others , Microtubule Associated | |
Podophyllotoxinone, a natural compound found in Dysosma versipellis, shows inhibitory activity against L1210 leukemia and KB cells in vitro. | |||
T0380 | Bicalutamide | ICI-176334 | Androgen Receptor , Autophagy |
Bicalutamide (ICI-176334), a synthetic, nonsteroidal antiandrogen, competitively binds to cytosolic androgen receptors in target tissues, thereby inhibiting the receptor binding of androgens. | |||
T8858 | DTHIB | HSP | |
DTHIB robustly inhibits the HSF1 cancer gene signature and prostate cancer cell proliferation. | |||
T7690 | 2-hydroxy Flutamide | Androgen Receptor | |
2-hydroxy Flutamide is competitive inhibition of androgen receptor (AR) for the treatment of prostate cancer | |||
TN2097 | Pomolic acid | Apoptosis , Caspase , HIV Protease , AMPK | |
Pomolic acid has anti-cancer, anti-inflammatory and apoptotic activities, it can induce apoptosis in SK-OV-3 cells, which is mediated by the mitochondrial-mediated intrinsic and death receptor-induced extrinsic pathways. | |||
T60051 | VPC-18005 | Others | |
VPC-18005 is a luciferase inhibitor. VPC-18005 inhibits ERG-induced transcription and interacts directly with the ERG-ETS domain thereby disrupting the ERG binding to DNA. | |||
T3160 | HUHS015 | Others | |
HUHS015 is a potent PCA-1/ALKBH3 inhibitor. | |||
T8217 | Enzalutamide carboxylic acid | Androgen Receptor , Drug Metabolite | |
Enzalutamide carboxylic acid is an antagonist of androgen receptor (AR) . | |||
T21740 | RD162 | Androgen Receptor | |
RD162 is a non-steroidal antiandrogen (NSAA) specifically binding to the androgen receptor (AR). | |||
T9721 | ML339 | CXCR | |
ML339 a selective inhibitor of CXCR6(IC50 = 140 nM) with no response when screened against CXCR5 and CXCR4. | |||
T1134 | Clofoctol | Antibacterial , Antibiotic | |
Clofoctol is a bacteriostatic antibiotic with activity against Gram-positive bacteria, used in the treatment of upper and lower respiratory tract infections. | |||
T39695 | ARD-2128 | Androgen Receptor | |
ARD-2128 is a highly potent, orally bioavailable PROTAC (proteolysis-targeting chimera) degrader of the androgen receptor (AR), effectively diminishing AR protein levels, suppressing AR-regulated gene expression in tumor... | |||
T12928 | SK33 | Androgen Receptor | |
SK33 is a potent and tissue selective anti-androgen agent. SK33 reduces androgen receptor (AR) transcriptional activity. | |||
T25492 | Hepln-13 | Hepln 13,Hepln13 | c-Met/HGFR |
Hepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis. | |||
T9266 | Fatostatin | Lipid , Fatty Acid Synthase | |
Fatostatin is a specific inhibitor of SREBP activation, it impairs the activation of SREBP-1 and SREBP-2. Fatostatin binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. | |||
T3324 | Lycorine | Galanthidine,Narcissine,Amarylline,Belamarine,Licorine | Apoptosis , Virus Protease , Antibacterial , AChR , Fatty Acid Synthase |
Lycorine (Narcissine) inhibits protein synthesis and may inhibit ascorbic acid biosynthesis, although studies on the latter are controversial and inconclusive. |